Parnell Pharmaceuticals Holdings Ltd (OTCMKTS:PARNF – Get Free Report)’s share price rose 37.5% on Thursday . The company traded as high as $0.19 and last traded at $0.17. Approximately 10,000 shares were traded during mid-day trading, a decline of 53% from the average daily volume of 21,500 shares. The stock had previously closed at $0.12.
Parnell Pharmaceuticals Price Performance
About Parnell Pharmaceuticals
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal – U.S., Production Animal – Rest of World, and Manufacturing Operations.
Further Reading
- Five stocks we like better than Parnell Pharmaceuticals
- What is the S&P/TSX Index?
- Bloom Energy: Powering the Future With Decentralized Energy
- What is a SEC Filing?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What is the S&P 500 and How It is Distinct from Other Indexes
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
